Immediate Impact

1 from Science/Nature 68 standout
Sub-graph 1 of 23

Citing Papers

Genomic surveillance for antimicrobial resistance — a One Health perspective
2023 Standout
Trends in peptide drug discovery
2021 Standout
2 intermediate papers

Works of M Javaloyas being referenced

Substitution of Nevirapine, Efavirenz, or Abacavir for Protease Inhibitors in Patients with Human Immunodeficiency Virus Infection
2003
Epidemiology and Prognosis of Bacteremia: A 10-y Study in a Community Hospital
2002

Author Peers

Author Last Decade Papers Cites
M Javaloyas 70 230 21 176 136 14 348
Michael S Boger 92 96 32 48 71 18 338
A. I. M. Hoepelman 166 107 22 64 46 21 340
José Ramón Paño 88 192 25 82 40 19 369
Laurence Maulin 123 143 35 42 115 19 313
Otto Sussmann 127 189 30 110 60 15 335
Sara Leone 125 160 29 57 40 15 332
Heloise Buys 113 119 37 55 96 25 366
Alberto Martín-Hidalgo 130 130 32 53 116 13 395
Mezgebe Berhe 66 297 6 222 35 25 371
Robert Yarrish 149 165 35 53 46 16 395

All Works

Loading papers...

Rankless by CCL
2026